Blueprint Medicines Corp at Goldman Sachs Global Healthcare Conference Transcript
Good morning, everyone. Thanks for joining us. We're really pleased to have the Blueprint Medicines Company with us. We have Kate Haviland, CEO; and Becker Hewes, CMO.
Questions & Answers
With that, Kate, to start here, how is Blueprint evolving under new leadership? Have there been any surprises that you've -- as you've stepped into the CEO role, any changes to strategy?
Yes. So first of all, Salveen, thank you for having us here. We really appreciate the opportunity, and we appreciate Goldman Sachs inviting us for this event. So really, no, I mean I think one of the great benefits of the leadership kind of succession and evolution at Blueprint is that the opportunity for myself and other members of our team to really -- who have been with the company for multiple years and have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
